165 related articles for article (PubMed ID: 35510091)
41. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
42. Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate.
Avni T; Babitch T; Ben-Zvi H; Hijazi R; Ayada G; Atamna A; Bishara J
Int J Infect Dis; 2020 Jan; 90():237-242. PubMed ID: 31672656
[TBL] [Abstract][Full Text] [Related]
43. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
Madoff SE; Urquiaga M; Alonso CD; Kelly CP
Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
[TBL] [Abstract][Full Text] [Related]
44. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
[TBL] [Abstract][Full Text] [Related]
45. Low vitamin D level and impact on severity and recurrence of Clostridium difficile infections.
Abdelfatah M; Nayfe R; Moftakhar B; Nijim A; El Zoghbi M; Donskey CJ; Kandil H; Watkins RR
J Investig Med; 2015 Jan; 63(1):17-21. PubMed ID: 25479065
[TBL] [Abstract][Full Text] [Related]
46. Microbiota in
Gazzola A; Panelli S; Corbella M; Merla C; Comandatore F; De Silvestri A; Piralla A; Zuccaro V; Bandi C; Marone P; Cambieri P
Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32911854
[No Abstract] [Full Text] [Related]
47. Recurrent Clostridium difficile infection among Medicare patients in nursing homes: A population-based cohort study.
Zilberberg MD; Shorr AF; Jesdale WM; Tjia J; Lapane K
Medicine (Baltimore); 2017 Mar; 96(10):e6231. PubMed ID: 28272217
[TBL] [Abstract][Full Text] [Related]
48. The burden of Clostridioides difficile on COVID-19 hospitalizations in the USA.
Sohal A; Chaudhry H; Singla P; Sharma R; Kohli I; Dukovic D; Prajapati D
J Gastroenterol Hepatol; 2023 Apr; 38(4):590-597. PubMed ID: 36662626
[TBL] [Abstract][Full Text] [Related]
49. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020.
Okafor CM; Clogher P; Olson D; Niccolai L; Hadler J
Emerg Infect Dis; 2023 May; 29(5):877-87. PubMed ID: 37081745
[TBL] [Abstract][Full Text] [Related]
50. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
Kimura T; Stanhope S; Sugitani T
J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648
[TBL] [Abstract][Full Text] [Related]
51. Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data.
Endo K; Mizuno K; Takeuchi M; Kawakami K
Anaerobe; 2023 Feb; 79():102693. PubMed ID: 36623703
[TBL] [Abstract][Full Text] [Related]
52. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
53. Risk factors and impact of Clostridium difficile recurrence on haematology patients.
Scappaticci GB; Perissinotti AJ; Nagel JL; Bixby DL; Marini BL
J Antimicrob Chemother; 2017 May; 72(5):1488-1495. PubMed ID: 28186243
[TBL] [Abstract][Full Text] [Related]
54. Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren.
Predrag S; Kuijper EJ; Nikola S; Vendrik KEW; Niko R
Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):509-516. PubMed ID: 31713000
[TBL] [Abstract][Full Text] [Related]
55. Real-World Experience with Bezlotoxumab for Prevention of Recurrence of
Escudero-Sánchez R; Ruíz-Ruizgómez M; Fernández-Fradejas J; García Fernández S; Olmedo Samperio M; Cano Yuste A; Valencia Alijo A; Díaz-Pollán B; Rodríguez Hernández MJ; Merino De Lucas E; Martín Segarra O; Sáez Bejar C; Armiñanzas Castillo C; Gutiérrez Gutiérrez B; Rodríguez-Pardo D; Ramos Martínez A; De La Torre Cisneros J; López-Medrano F; Cobo Reinoso J
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33374989
[TBL] [Abstract][Full Text] [Related]
56. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
Orenstein R; Dubberke ER; Khanna S; Lee CH; Yoho D; Johnson S; Hecht G; DuPont HL; Gerding DN; Blount KF; Mische S; Harvey A
BMC Infect Dis; 2022 Mar; 22(1):245. PubMed ID: 35279084
[TBL] [Abstract][Full Text] [Related]
57. Risk of complications and mortality following recurrent and non-recurrent Clostridioides difficile infection: a retrospective observational database study in England.
Enoch DA; Murray-Thomas T; Adomakoh N; Dedman D; Georgopali A; Francis NA; Karas A
J Hosp Infect; 2020 Dec; 106(4):793-803. PubMed ID: 32987118
[TBL] [Abstract][Full Text] [Related]
58. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent
van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ
Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163
[TBL] [Abstract][Full Text] [Related]
59. Association of Community Factors with Hospital-onset
Zacharioudakis IM; Zervou FN; Shehadeh F; Mylona EK; Mylonakis E
EClinicalMedicine; 2019 Feb; 8():12-19. PubMed ID: 31193719
[TBL] [Abstract][Full Text] [Related]
60. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients.
Abu-Sbeih H; Choi K; Tran CN; Wang X; Lum P; Shuttlesworth G; Stroehlein JR; Okhuysen PC; Wang Y
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):128-134. PubMed ID: 30339561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
